- Home
- BCYC vs KFS Comparison
BCYC vs KFS Comparison
Compare BCYC & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- KFS
- Stock Information
- Founded
- BCYC 2009
- KFS 1989
- Country
- BCYC United Kingdom
- KFS United States
- Employees
- BCYC N/A
- KFS N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- BCYC Health Care
- KFS Finance
- Exchange
- BCYC Nasdaq
- KFS Nasdaq
- Market Cap
- BCYC 492.1M
- KFS 417.8M
- IPO Year
- BCYC 2019
- KFS 1996
- Fundamental
- Price
- BCYC $6.90
- KFS $14.39
- Analyst Decision
- BCYC Buy
- KFS
- Analyst Count
- BCYC 11
- KFS 0
- Target Price
- BCYC $22.91
- KFS N/A
- AVG Volume (30 Days)
- BCYC 233.2K
- KFS 69.9K
- Earning Date
- BCYC 10-30-2025
- KFS 11-05-2025
- Dividend Yield
- BCYC N/A
- KFS N/A
- EPS Growth
- BCYC N/A
- KFS N/A
- EPS
- BCYC N/A
- KFS N/A
- Revenue
- BCYC $19,281,000.00
- KFS $119,287,000.00
- Revenue This Year
- BCYC N/A
- KFS N/A
- Revenue Next Year
- BCYC $0.27
- KFS N/A
- P/E Ratio
- BCYC N/A
- KFS N/A
- Revenue Growth
- BCYC N/A
- KFS 12.05
- 52 Week Low
- BCYC $6.10
- KFS $7.06
- 52 Week High
- BCYC $28.67
- KFS $16.80
- Technical
- Relative Strength Index (RSI)
- BCYC 39.17
- KFS 54.05
- Support Level
- BCYC $6.84
- KFS $14.00
- Resistance Level
- BCYC $7.32
- KFS $14.43
- Average True Range (ATR)
- BCYC 0.36
- KFS 0.31
- MACD
- BCYC 0.01
- KFS 0.02
- Stochastic Oscillator
- BCYC 14.56
- KFS 80.51
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.